Lorglumide sodium salt
Modify Date: 2024-01-07 21:19:23
Lorglumide sodium salt structure
|
Common Name | Lorglumide sodium salt | ||
|---|---|---|---|---|
| CAS Number | 1021868-76-7 | Molecular Weight | 481.388 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H31Cl2N2NaO4 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
Use of Lorglumide sodium saltLorglumide sodium salt (CR-1409 sodium salt) is a potent cholecystokinin (CCK) receptor antagonist[1]. |
| Name | Sodium 4-{[4-carboxylato-1-(dipentylamino)-1-oxo-2-butanyl]carbamoyl}-1,2-dichlorobenzene |
|---|---|
| Synonym | More Synonyms |
| Description | Lorglumide sodium salt (CR-1409 sodium salt) is a potent cholecystokinin (CCK) receptor antagonist[1]. |
|---|---|
| Related Catalog | |
| Target |
CCK[1] |
| References |
| Molecular Formula | C22H31Cl2N2NaO4 |
|---|---|
| Molecular Weight | 481.388 |
| Exact Mass | 480.155853 |
| Storage condition | 2-8℃ |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| RTECS | SA3680700 |
|
Different downstream signalling of CCK1 receptors regulates distinct functions of CCK in pancreatic beta cells.
Br. J. Pharmacol. 172 , 5050-67, (2015) Cholecystokinin (CCK) is secreted by intestinal I cells and regulates important metabolic functions. In pancreatic islets, CCK controls beta cell functions primarily through CCK1 receptors, but the si... |
|
|
Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse.
Peptides 16(7) , 1229-34, (1995) Various doses of sulfated cholecystokinin octapeptide (CCK-8s) injected intracerebroventricularly (ICV) alone did not show any antinociceptive effect. CCK-8s (0.01-1 ng) pretreated ICV for 10 min dose... |
|
|
Expression of the transcription factor Egr-1 in pancreatic acinar cells following stimulation of cholecystokinin or Gαq-coupled designer receptors.
Cell Physiol. Biochem. 33(5) , 1411-25, (2014) BACKGOUND/AIMS: The injection of cerulein, an analogue of the pancreatic secretagogue cholecystokinin (CCK), induces acute pancreatitis in mice that is accompanied by the synthesis of the transcriptio... |
| Sodium 4-{[4-carboxylato-1-(dipentylamino)-1-oxobutan-2-yl]carbamoyl}-1,2-dichlorobenzene |
| Sodium 4-{[4-carboxylato-1-(dipentylamino)-1-oxo-2-butanyl]carbamoyl}-1,2-dichlorobenzene |
| MFCD00083183 |